Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All OneMedNet Corp filings on SEC EDGAR ↗
OneMedNet reported year-to-date contracted bookings of $18.76 million as of November 6, 2026, representing a significant increase over 2025 levels. The company also released a growth recap titled 'OneMedNet by the Numbers' highlighting its commercial trajectory and AI-driven real-world data platform performance.
OneMedNet reported preliminary Q3 2026 revenue of approximately $1 million, a 465% increase year-over-year, driven by the scaling of its de-identified data delivery infrastructure. The company also provided Q4 2026 revenue guidance of $12 million to $14 million, reflecting a significant weighting of revenue toward the end of the year as it delivers on its expanded sales funnel.
OneMedNet Corporation has regained compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing. The company's common stock maintained a closing bid price of at least $1.00 per share for 10 consecutive business days from September 29, 2026, through October 12, 2026. Nasdaq has officially closed the matter, resolving the deficiency notice originally issued on April 14, 2026.
Jeffrey Yu, CMO, bought 45,126 shares of OneMedNet Corp at $5.54 a share, worth $250K in total on Oct 9, 2026. Shares held after the trade: 896,840 (+5.3%).
OneMedNet Insider Thomas Kosasa Buys $750K of Stock
Thomas Kosasa bought 129,758 shares of OneMedNet Corp at $5.78 a share, worth $750K in total on Oct 7, 2026. Shares held after the trade: 1,983,573 (+7.0%).
Aaron Green, CEO, sold 6,667 shares of OneMedNet Corp at $6.48 to $7.39 a share (average $7.16) in 2 transactions, worth $47.8K in total between Sep 22, 2026 and Sep 24, 2026. Shares held after the trade: 247,971 (-0.7%).
OneMedNet CFO Robert Lawrence Golden Sells $55.3K of Stock
Robert Lawrence Golden, CFO, sold 8,500 shares of OneMedNet Corp at $6.30 to $6.63 a share (average $6.50) in 3 transactions, worth $55.3K in total between Sep 14, 2026 and Sep 21, 2026. Shares held after the trade: 91,291 (-3.2%).
OneMedNet Corporation is implementing a 1-for-10 reverse stock split of its common stock, effective September 29, 2026. The action is intended to bring the company into compliance with Nasdaq's minimum bid price requirement for continued listing. The split will reduce the outstanding share count from approximately 60.1 million to approximately 6.0 million shares.
OneMedNet Corporation held its 2026 Annual Meeting of Stockholders on September 18, 2026, where shareholders elected three Class III directors and ratified WithumSmith+Brown, PC as the independent auditor. Stockholders also approved an amendment to the 2022 Equity Incentive Plan to increase the share reserve by 1,000,000 shares and authorized a reverse stock split at a ratio between 1-for-5 and 1-for-20.